Episode Details
Back to EpisodesBioidentical Hormones, Circulation, and Rebuilding Intimacy Post-Cancer
Description
Cancer treatment can profoundly affect intimacy and marital connection, often leading to challenges in sexual health and relationships. Many couples face issues like decreased sexual function and confidence after chemotherapy, yet these challenges are not insurmountable.
Dr. Prato provides practical marriage advice and integrative tools to help navigate these impacts, offering hope and solutions for a fulfilling connection post-treatment.
🎯 What You’ll Learn in This Episode:
- Why cancer treatment affects libido and performance
- The role of sleep and cortisol in sexual health
- When bioidentical hormones may be appropriate
- Safe considerations for testosterone microdosing
- When localized estriol therapy may be considered
- The role of circulation in erectile function
- Natural nitric oxide support strategies
- Why emotional connection matters just as much as biology
📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: www.envita.com
📞 Speak with a care coordinator: 866-830-4576
“Intimacy is not lost after cancer — it must be rebuilt with wisdom, patience, and the right support.”
Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.
You can read the full peer-reviewed study at:
https://www.scirp.org/journal/paperinformation?paperid=132493